USA15-0 — Portland, Oregon

USA15-0 is a clinical research site located in Portland, Oregon, United States 97239.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

USA15-0 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumors.

Sponsors: DualityBio Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portland

Browse all research sites in Oregon · View every site in Portland

• Oregon Health and Science University, CHH1
• Oregon Health & Science University (OHSU), Site 048
• Oregon Health & Science University OHS University
• Oregon Health and Science University, Doernbecher Children's Hospital
• Oregon Health Sciences University Hospital
• Oregon Health & Science University OHSU Knight Cancer Institute
• Oregon Health and Science University /ID# 149774
• Legacy Emanuel Research Hospital Portland
• Oregon Health and Science University /ID# 221801
• Oregon Health Sciences University SC-6
• Oregon Health and Science University Dept. Hematologic Malignancies
• VA Portland Health Care Services

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USA15-0?

USA15-0 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USA15-0 conducted?

USA15-0 has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumors.

Is USA15-0 accredited by Crixeo Clinical Trials?

USA15-0 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USA15-0?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.